Evidence map›Paper›PMID 34269506›Full record

ArticleAngewandte Chemie (International ed. in English)2021

Asymmetric Alkylation of Ketones Catalyzed by Engineered TrpB.

Ella J Watkins-Dulaney, Noah P Dunham, Sabine Straathof, Soma Turi, Frances H Arnold, Andrew R Buller

Open access · greenAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Engineered Biocatalytic Synthesis of β-N-Substituted-α-Amino Acids.Angewandte Chemie (International ed. in English) · 2023
    Article
  11. Article
  12. New Additions to the Arsenal of Biocatalysts for Noncanonical Amino Acid Synthesis.Current opinion in green and sustainable chemistry · 2022
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ella J Watkins-DulaneyDivision of Biology and Biological Engineering, California Institute of Technology, MC 210-41, 1200 E. California Boulevard, Pasadena, CA, 91125, USA.ORCID 0000-0002-0585-1598
Noah P DunhamDivision of Chemistry and Chemical Engineering, California Institute of Technology, MC 210-41, 1200 E. California Boulevard, Pasadena, CA, 91125, USA.ORCID 0000-0001-8006-9566
Sabine StraathofDivision of Chemistry and Chemical Engineering, California Institute of Technology, MC 210-41, 1200 E. California Boulevard, Pasadena, CA, 91125, USA.
Soma TuriDivision of Chemistry and Chemical Engineering, California Institute of Technology, MC 210-41, 1200 E. California Boulevard, Pasadena, CA, 91125, USA.
Frances H ArnoldDivision of Biology and Biological Engineering, California Institute of Technology, MC 210-41, 1200 E. California Boulevard, Pasadena, CA, 91125, USA.ORCID 0000-0002-4027-364X
Andrew R BullerDepartment of Chemistry, University of Wisconsin-Madison, 1101 University Avenue, Madison, WI, 53706, USA.ORCID 0000-0002-9635-4844
California Institute of Technology · USUniversity of Wisconsin–Madison · US

Funding

Engineering in vivo biomolecular synthesis with non-standard building blocksDP2GM137417 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BULLER, ANDREW · 2019 to 2019
$2.2M
Development of a Biocatalytic Platform for Convergent Synthesis of Chiral AminesR01GM125887 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ARNOLD, FRANCES H · 2018 to 2021
$1.2M
Prenylated-Flavin Enzymes as a new Platform for Drug Synthesis and DiscoveryF32GM131620 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DUNHAM, NOAH PAUL · 2019 to 2020
$126k
foundation for the national institutes of health DP2-GM137417NIGMS NIH HHS DP2 GM137417NIGMS NIH HHS F32 GM131620NIGMS NIH HHS F32GM131620NIGMS NIH HHS R01 GM125887NIGMS NIH HHS R01GM125887
6 · The paper itself

Abstract

The β-subunit of tryptophan synthase (TrpB) catalyzes a PLP-mediated β-substitution reaction between indole and serine to form L-Trp. A succession of TrpB protein engineering campaigns to expand the enzyme's nucleophile substrate range has enabled the biocatalytic production of diverse non-canonical amino acids (ncAAs). Here, we show that ketone-derived enolates can serve as nucleophiles in the TrpB reaction to achieve the asymmetric alkylation of ketones, an outstanding challenge in synthetic chemistry. We engineered TrpB by directed evolution to catalyze the asymmetric alkylation of propiophenone and 2-fluoroacetophenone with a high degree of selectivity. In reactions with propiophenone, preference for the opposite product diastereomer emerges over the course of evolution, demonstrating that full control over the stereochemistry at the new chiral center can be achieved. The addition of this new reaction to the TrpB platform is a crucial first step toward the development of efficient methods to synthesize non-canonical prolines and other chirally dense nitrogen heterocycles.

Indexed as

Protein EngineeringAlkylationBiocatalysisKetonesMolecular StructureTryptophan SynthaseKetonesTryptophan Synthaseasymmetric catalysisbiocatalysisdirected evolutionketonesnitrogen heterocycles

Identifiers

PMID34269506
PMCPMC8440449
OpenAlexW3178657641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.